60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update)
Overview 60 Degrees Pharmaceuticals, Inc. (“60 Degrees ...
Sign in to continue:
Overview 60 Degrees Pharmaceuticals, Inc. (“60 Degrees ...
MultiSensor AI Holdings, Inc. - Key Investor Update from For...
Polomar Health Services, Inc. – SEC 8-K Report Summary (July...
TOMI Environmental Solutions Announces 1-for-3 Reverse Stock...
Wheeler Real Estate Investment Trust, Inc. Announces Exchang...
Zions Bancorporation, N.A. Reports Record Q2 2026 Earnings ...
Healthcare Triangle, Inc. Announces Key Shareholder Votes an...
Metropolitan Bank Holding Corp. Announces Increased Quarterl...
Elutia Announces Definitive Agreement to Sell SimpliDerm® Bu...
AGNC Investment Corp. Q2 2026 Financial Results: Detailed In...